Family Med Medical News about Migrainous Vertigo; Intravenous Methylprednisolone

Become a Member Today!
Register

Most Viewed Abstracts

1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

2. Omega-3 fatty acids for bipolar disorder

3. Is folic acid good for everyone

4. ACS Releases Guidelines for HPV Vaccination

5. Vitamin D - A review Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Migrainous Vertigo Responsive to Intravenous Methylprednisolone: Case Reports
Headache: The Journal of Head and Face Pain, 06/26/09

Prakash S et al. - Migrainous vertigo (MV) is a newer evolving concept in which vertigo is causally related to migraine. The authors report 4 patients with MV. Episodes of severe MV of more than 1-day duration were successfully terminated by intravenous methylprednisolone (IV MPS) in 2 patients. Two other patients who had attacks of MV almost daily also showed complete response to IV MPS.

<< Previous
Personality Types and Performance on Aptitude and Achievement...

Next >>
Thyroid volume changes during pregnancy and after delivery in an...